A component of VLDL, chylomicrons, and HDL, with the ability to modulate lipid metabolism. Apo CI is being investigated as a target of therapeutic strategies for Alzheimer's, diabetes, and obesity-related disorders.
Specifications
- Purity:
- ≥95% (SDS-PAGE)
- Source Material:
- Human Plasma
- MW (Molecular Weight):
- 6.6 kDa
- Form:
- Lyophilized
- Buffer:
- 10 mM NH4HCO3, pH 7.4
- Protein Determination:
- Modified Lowry
- UniProt ID:
- P02654
- Gene ID:
- APOC1, 341
- Storage Temperature:
- ≤ -20°C
- Shipped On:
- Coolant Pack
- Standard Grade:
- Yes
- Grade:
- Standard Grade
- Product Type:
- Transport & Binding Proteins
- Research Area:
- Cardiovascular, Metabolism & Endocrinology
- Application:
- In Vitro Diagnostics (IVD), Antibody & Antisera Production
